Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy

NCT01572597 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

Interventions

DRUG: 10RAC+acetylcystein
DRUG: 10RAC+metronidazole

Sponsor

Buddhist Tzu Chi General Hospital